Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

…, I Hussain, R Isnard, C Izumi, G Jondeau, E Juneman… - The Lancet, 2022 - thelancet.com
Background Placement of an interatrial shunt device reduces pulmonary capillary wedge
pressure during exercise in patients with heart failure and preserved or mildly reduced ejection …

Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial

…, L Planting, M Miller, Y Rodriguez, E Juneman… - Jama, 2011 - jamanetwork.com
Context Arterial grafts are thought to be better conduits than saphenous vein grafts for coronary
artery bypass grafting (CABG) based on experience with using the left internal mammary …

Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

…, AJ Klein, M Forsberg, D Kapoor, E Juneman… - The Lancet, 2018 - thelancet.com
Background Few studies have examined the efficacy of drug-eluting stents (DES) for reducing
aortocoronary saphenous vein bypass graft (SVG) failure compared with bare-metal stents …

IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias

…, H Tang, S Ciftci-Yilmaz, E Juneman… - Blood, The Journal …, 2021 - ashpublications.org
Previous reports indicate that IL18 is a novel candidate gene for diastolic dysfunction in
sickle cell disease (SCD)–related cardiomyopathy. We hypothesize that interleukin-18 (IL-18) …

Human induced pluripotent stem cell–derived cardiomyocyte patch in rats with heart failure

…, P Sanchez, GG Repetti, E Juneman… - The Annals of Thoracic …, 2019 - Elsevier
Background To treat chronic heart failure (CHF), we developed a robust, easy to handle
bioabsorbable tissue-engineered patch embedded with human neonatal fibroblasts and human …

Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction

HM Thai, E Juneman, J Lancaster… - Cell …, 2009 - journals.sagepub.com
This study was designed to determine if a viable biodegradable three-dimensional
fibroblast construct (3DFC) patch implanted on the left ventricle after myocardial infarction (MI) …

[HTML][HTML] Cellular therapeutics for heart failure: focus on mesenchymal stem cells

…, DT Harris, S Goldman, E Juneman - Stem Cells …, 2017 - hindawi.com
Resulting from a various etiologies, the most notable remains ischemia; heart failure (HF)
manifests as the common end pathway of many cardiovascular processes and remains among …

Increased cardiac arrhythmogenesis associated with gap junction remodeling with upregulation of RNA-binding protein FXR1

…, C Cover, AA Wang, IR Chinyere, EB Juneman… - Circulation, 2018 - Am Heart Assoc
Background: Gap junction remodeling is well established as a consistent feature of human
heart disease involving spontaneous ventricular arrhythmia. The mechanisms responsible for …

The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure

L Saleh, E Juneman… - Catheterization and …, 2011 - Wiley Online Library
Coronary artery angiography remains an important procedure for the assessment of coronary
arteries. It requires injection of iodinated contrast for the opacification of coronary arteries. …

[HTML][HTML] Aortic valve disorders and left ventricular assist devices

…, T Acharya, E Betterton, E Juneman… - Frontiers in …, 2023 - frontiersin.org
Aortic valve disorders are important considerations in advanced heart failure patients being
evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic …